rs117776183
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4BP2BA1BP7
This summary comes from the ClinGen Evidence Repository: This intronic variant has a MAF of 0.008015 (0.8015%, 545/67996 alleles) in the European (non-Finnish) subpopulation of gnomAD v3.1.2 cohort is ≥0.0015 (0.15%) (BA1). It is detected in a homozygous state in 9 individuals within the European (non-Finnish) population in gnomAD v2.1.1 (NB: MAF for this allele within the European (non-Finnish) population of gnomAD v2.1.1 is 0.008492 (0.8492%, 1097/129174 alleles) (BP2). It has a SpliceAI Δ score of ≤0.20 (0.00) (BP4). Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score 0.666583 is <2.0). The variant is the reference nucleotide in at least 3 mammalian species. It is not the reference nucleotide in any primate (BP7). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BP2, BP4, BP7. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10014719/MONDO:0011071/008
Frequency
Consequence
NM_001754.5 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00462 AC: 702AN: 152072Hom.: 3 Cov.: 31
GnomAD3 exomes AF: 0.00438 AC: 1102AN: 251454Hom.: 11 AF XY: 0.00413 AC XY: 561AN XY: 135908
GnomAD4 exome AF: 0.00705 AC: 10220AN: 1450342Hom.: 54 Cov.: 29 AF XY: 0.00681 AC XY: 4918AN XY: 722284
GnomAD4 genome AF: 0.00461 AC: 702AN: 152190Hom.: 3 Cov.: 31 AF XY: 0.00399 AC XY: 297AN XY: 74406
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome Benign:1
This intronic variant has a MAF of 0.008015 (0.8015%, 545/67996 alleles) in the European (non-Finnish) subpopulation of gnomAD v3.1.2 cohort is ≥0.0015 (0.15%) (BA1). It is detected in a homozygous state in 9 individuals within the European (non-Finnish) population in gnomAD v2.1.1 (NB: MAF for this allele within the European (non-Finnish) population of gnomAD v2.1.1 is 0.008492 (0.8492%, 1097/129174 alleles) (BP2). It has a SpliceAI Δ score of ≤0.20 (0.00) (BP4). Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score 0.666583 is <2.0). The variant is the reference nucleotide in at least 3 mammalian species. It is not the reference nucleotide in any primate (BP7). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BP2, BP4, BP7. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at